Related Experiment Video
Updated: May 11, 2026
28:13
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
[General therapeutic strategy for atrial fibrillation]
Takashi Kaneshiro1, Kazutaka Aonuma
1Cardiovascular Division, Faculty of Medicine, University of Tsukuba.
Summary
Therapeutic strategies for atrial fibrillation (AF) involve preventing clots and managing heart rhythm. New anticoagulants and catheter ablation offer options, but optimal AF management remains unclear.
Area of Science:
- Cardiology
- Pharmacology
- Electrophysiology
Context:
- Atrial fibrillation (AF) management involves two main strategies: preventing thromboembolic events and controlling heart rhythm.
- Warfarin's efficacy is established, but newer anticoagulants like dabigatran and rivaroxaban present choices and clinical confusion.
- The AFFIRM study questioned the superiority of rhythm control, yet catheter ablation indications for AF have expanded.
Purpose:
- To review the current therapeutic strategies for atrial fibrillation.
- To highlight the complexities in choosing anticoagulants and rhythm control methods for AF patients.
Summary:
- Current AF treatment involves anticoagulation and rhythm/rate control.
- New oral anticoagulants (NOACs) offer benefits but complicate treatment decisions.
- The role of catheter ablation in rhythm control is expanding, yet overall AF strategy remains debated.
Impact:
- Clarifies the evolving landscape of atrial fibrillation treatment.
- Provides insights into the ongoing debate regarding optimal AF management strategies.
- Highlights the need for evidence-based guidelines to navigate complex therapeutic choices in AF.
Related Concept Videos
01:25Dysrhythmias VI: Management of Dysrhythmias
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
01:25ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.